Experts unpack new myeloma regimens—quadruplet induction, dual maintenance, earlier smoldering therapy—plus real-world access and cost hurdles.
Multiple Myeloma Today: Navigating a Shifting Treatment Landscape
The panelists examined the significant progress made in frontline multiple myeloma treatment while emphasizing that true satisfaction will only come when more patients achieve a durable cure and can transition off maintenance therapy entirely, identifying MRD-guided treatment discontinuation as one of the most promising pathways toward that goal.
Advertisement
Advertisement
Trending on AJMC
1
Special Report: The Oncology Care Model, 10 Years Later
2
How Hospital Specialty Pharmacies Are Closing the Pharmacy Desert Gap
3
Patients on GLP-1s Increasingly Carry Diagnoses for New Indications
4
Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox
5